David Liu
About David Liu
David Liu is the Associate Director of R&ED IT Digital Capability Management at Bristol Myers Squibb, with a background in cloud solutions and data orchestration platforms for R&D organizations.
Current Role at Bristol Myers Squibb
David Liu serves as the Associate Director for R&ED IT Digital Capability Management at Bristol Myers Squibb. In this role, he focuses on developing and managing digital capabilities to support the company's research and early development initiatives. His work is instrumental in helping scientists at the company discover novel, safer, and more cost-effective therapeutics.
Previous Position at Celgene
Before joining Bristol Myers Squibb, David Liu worked at Celgene as the Associate Director of R&D Cloud Solutions from 2019 to 2020. During his one-year tenure, he was responsible for architecting cloud-native machine learning pipeline solutions to advance the company's research and development efforts.
Education and Academic Background
David Liu holds an Executive MBA from The Wharton School, where he studied from 2021 to 2023. He also earned a Bachelor of Science degree in Biomathematics, Bioinformatics, and Computational Biology from the University of California San Diego. His strong educational background provides a solid foundation for his expertise in bioinformatics and computational biology.
Industry Experience
David Liu has a decade of experience in the pharmaceutical and biotech industry. Over the years, he has successfully built and architected data engineering and analytics-driven cloud frameworks for various R&D organizations, ranging from small to large entities. His work has focused on leveraging digital transformation strategies to enhance the development of new therapeutics.
Key Projects and Innovations
Throughout his career, David Liu has developed high throughput data orchestration platforms for research and development organizations. Additionally, he has architected cloud-native machine learning pipeline solutions, all aimed at supporting innovative digital transformation in the pharmaceutical and biotech fields.